NutraCea Reports Full Year 2010 Financial Results

Despite the reduction in total revenues in 2010, consolidated gross profit rose 13.2% to $7.0 million, or 22.1% of revenues, compared to a gross profit of $6.2 million, or 18.6% of revenue for 2009.

4/4/2011 --- NutraCea, a world leader in production and marketing of stabilized rice bran (SRB), rice bran oil (RBO) and their derivative products, announced full year financial results for the year ended December 31, 2010.

Divestiture of non-core businesses, including the sale of its nutraceutical distribution business, its infant cereal product line and its equine brands products, reduced revenues by $2.6 million or 7.8% in 2010 compared to 2009. This revenue reduction was partially offset by an increase of $1.0 million in the bio-refining segment, resulting in a net decline in 2010 revenues of $1.6 million or 4.8%. Core SRB product revenues held steady in a difficult business environment.

Despite the reduction in total revenues in 2010, consolidated gross profit rose 13.2% to $7.0 million, or 22.1% of revenues, compared to a gross profit of $6.2 million, or 18.6% of revenue for 2009. Gross profit margin in the SRB segment grew to 36.9% for 2010 from 23.3% for 2009. This improvement resulted primarily from the sale of low margin and non-core product lines combined with payroll and operating cost reductions at production facilities. Gross profit in the bio-refining segment was down slightly with improved pricing offset by higher plant maintenance costs included in cost of goods sold.

Operating expenses decreased by $14.6 million or 41.1% in 2010. Cost cutting efforts across the business that began in 2009 and continued in 2010 resulted in a combined $6.0 million reduction in SG&A and professional fees for full year 2010. The net loss attributable to NutraCea shareholders of $32.1 million, or $(0.17) per basic and diluted share, previously reported for 2009 was reduced by $16.4 million to a net loss attributable to NutraCea shareholders of $15.7 million, or $(0.08) per basic and diluted share for 2010. The 2010 loss represents a 51% improvement from 2009 and a $48.9 million or 76% improvement from the $64.6 million net loss reported for 2008.

W. John Short, Chairman and CEO, commented, "The restructuring initiatives that began in 2009 and continued in 2010 allowed NutraCea to successfully emerge from Chapter 11, settle class action lawsuits within D&O policy limits, shed underperforming and non-core businesses, pay our secured creditors in full, fund ongoing operations, settle with the SEC, pay the significant legal and restructuring costs related to the Chapter 11 process and position the Company to pay unsecured creditors in full without impairing our shareholders. To date, we have paid approximately 70% of our secured and unsecured creditor obligations. We expect to pay our remaining obligations to unsecured creditors during the 2011 calendar year.

"We are pleased to report that our rice bran oil bio-refining business, currently represented by Irgovel, was operationally cash flow positive in 2010. In addition, in January 2011 we sold to Alothon Group, through its AF Bran Holdings subsidiaries, a minority interest in our subsidiary that owns Irgovel. Their investment will allow us to move forward with technology improvements and a capacity expansion that should significantly improve cash flow and profitability in the Brazilian operation.

"We are proud of the improvement in all aspects of our business in 2010, especially the significant increases in operating gross margins and the major reductions in expenses resulting from our restructuring. And while we expect to show further improvement across all business segments in 2011 and beyond, we will not be satisfied until all segments of the business are generating positive cash flow and earning an attractive after tax return for our shareholders.

"There are still challenges to overcome. However, as a leaner, more cost-efficient company with a significantly stronger management team, we believe we are well positioned to continue to deliver improved performance in our core SRB and rice oil bio-refining businesses in 2011 and beyond."